SCR-A003

N/A

Report date: 2025/07/11 16:10:32

Base Information

Drug NameSCR-A003
Drug Alias NameSCR-A003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker
Mechanisms of ActionAnti-LIV-1DNA topoisomerase I inhibitors
TargetsZinc transporter ZIP6DNA topoisomerase I
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSimcere Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSimcere Pharmaceutical Group Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A